DNA 定序市场规模、份额、成长分析、按产品和服务、按技术、按工作流程、按应用、按最终用途、按地区 - 行业预测，2024-2031 年

2022年全球DNA定序市场规模估值为105亿美元，从2023年的122.9亿美元成长到2031年的440亿美元，在预测期（2024-2031年）复合年增长率为17.12%，预计还将增长。

在下一代和全基因组分析技术快速进步的推动下，美国DNA 定序市场预计将出现强劲成长。 Illumina 的 NGS 等创新透过平行处理能力显着提高定序通量和速度，从而实现了多个 DNA 片段的同时分析，从而彻底改变了基因组学。这些资料处理速度使研究人员和医疗保健专业人员能够有效地提取诊断和个人化医疗的关键遗传见解。为了展示这一趋势，Illumina 于 2023 年 3 月推出了云端基础的Connected Insights 计划，以简化临床 NGS资料处理。随着人们对基因组研究和个人化医疗的兴趣日益浓厚，DNA 定序已成为医疗保健领域的重要工具，为诊断、治疗策略和疾病预防方面的有希望的进步铺平了道路。

目录

介绍

• 研究目的
• 调查范围
• 定义

调查方法

• 资讯采购
• 二手资料和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 抑制因素和挑战
• 波特分析与影响
  • 竞争公司之间的敌对关係
  • 替代品的威胁
  • 买方议价能力
  • 新进入者的威胁
  • 供应商的议价能力

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2023）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 价格分析
• 技术进步
• 监管环境
• 案例研究
• 客户和购买标准分析

DNA 定序市场规模：依产品/服务及复合年增长率（2024-2031）

• 市场概况
• 消耗品
• 装置
• 服务

DNA 定序市场规模：依技术及复合年增长率（2024-2031）

• 市场概况
• 桑格序列
• 次世代定序
  • 全基因组定序（WGS）
  • 全EXOME定序 (WES)
  • 标靶定序和定序
• 第三代定序
  • 单分子即时定序（SMRT）
  • 奈米孔定序

DNA 定序市场规模：依工作流程及复合年增长率（2024-2031）

• 市场概况
• 预测定序
• 定序
• 资料分析

DNA 定序市场规模：依应用和复合年增长率（2024-2031）

• 市场概况
• 肿瘤学
• 生殖健康
• 临床研究
• 农业基因组学与法医学
• HLA型检测/免疫系统监测
• 总体基因体学、流行病学、药物开发
• 消费者基因体学
• 其他的

DNA 定序市场规模：依最终用途及复合年增长率（2024-2031）

• 市场概况
• 学术研究
• 临床研究
• 医院/诊所
• 製药和生物技术公司
• 其他用户

DNA 定序市场规模：按地区和复合年增长率（2024-2031）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 英国
  • 德国
  • 西班牙
  • 法国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东/非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争资讯

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2023）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分類的份额分析
  • 收益与前一年同期比较（2021-2023）

主要企业简介

• Illumina, Inc.
• Thermo Fisher Scientific
• Pacific Biosciences（PacBio）
• Oxford Nanopore Technologies
• Qiagen
• Agilent Technologies
• Bio-Rad Laboratories
• PerkinElmer
• Element Biosciences
• MGI（BGI Group）
• Genewiz
• Macrogen
• OncoDNA
• Hamilton Thorne
• DNASTAR
• Eurofins GATC Biotech
• Roche Diagnostics
• Wasatch BioLabs
• Integrated DNA Technologies（IDT）
• Genomatic AG

结论和建议

Global DNA Sequencing Market size was valued at USD 10.5 billion in 2022 and is poised to grow from USD 12.29 billion in 2023 to USD 44 billion by 2031, growing at a CAGR of 17.12% in the forecast period (2024-2031).

The US DNA sequencing market is set for robust growth, fueled by rapid advancements in Next-Generation and Whole-Genome Sequencing technologies. Innovations like Illumina's NGS have revolutionized genomics by significantly enhancing sequencing throughput and speed through parallel processing capabilities, enabling the analysis of multiple DNA segments simultaneously. This acceleration in data processing empowers researchers and healthcare professionals to extract critical genetic insights for diagnostics and personalized medicine effectively. Illustrating this trend, Illumina launched its Connected Insights cloud-based program in March 2023 to streamline clinical NGS data processing. As interest in genomic research and personalized medicine grows, DNA sequencing emerges as an indispensable tool in healthcare, paving the way for promising advancements in diagnostics, therapeutic strategies, and disease prevention.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Dna Sequencing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Dna Sequencing Market Segmental Analysis

Global DNA Sequencing Market is segmented by Product & Service, Technology, Workflow, Application, End-use and region. Based on Product & Service, the market is segmented into Consumables, Instruments, Services. Based on Technology, the market is segmented into Sanger Sequencing, Next-Generation Sequencing, Whole Genome Sequencing (WGS), Whole Exome Sequencing (WES), Targeted Sequencing & Resequencing, Third Generation Sequencing, Single-Molecule Real-Time Sequencing (SMRT), Nanopore Sequencing. Based on Workflow, the market is segmented into Grade. Based on Application, the market is segmented into Oncology, Reproductive Health, Clinical Investigation, Agrigenomics & Forensics, HLA Typing/Immune System Monitoring, Metagenomics, Epidemiology & Drug Development, Consumer Genomics, Others. Based on End-use, the market is segmented into Academic Research, Clinical Research, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Other Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Dna Sequencing Market

The primary catalyst propelling the DNA sequencing market is the increasing emphasis on personalized therapy. As modern healthcare shifts towards customized treatments, comprehensive genetic information becomes essential. DNA sequencing enables healthcare providers to tailor therapies to individual genetic profiles, enhancing treatment effectiveness while minimizing adverse effects. This demand is particularly pronounced in the oncology field, where precision medicine relies on genetic insights to inform targeted therapies. The rising application of genomics in clinical practices fuels market growth as healthcare systems prioritize precision medicine to improve patient outcomes, thereby driving the need for advanced sequencing technologies and services.

Restraints in the Global Dna Sequencing Market

The global DNA sequencing market is hindered by several constraints, primarily involving the significant costs associated with infrastructure and resource requirements. Despite a general decline in sequencing costs over time, many research institutions and healthcare providers, particularly in underdeveloped nations, encounter substantial challenges in acquiring the essential reagents, advanced equipment, and skilled personnel needed for effective sequencing operations. Moreover, the financial burden of data processing and storage can further escalate operational expenses. These economic limitations often restrict the implementation of cutting-edge sequencing technologies, particularly within smaller laboratories or facilities, thereby adversely affecting industry growth and limiting access to advanced genomic solutions.

Market Trends of the Global Dna Sequencing Market

The Global DNA Sequencing market is witnessing a significant trend towards the integration of artificial intelligence (AI) and machine learning (ML) technologies, focusing on enhancing data analysis and interpretation capabilities. These advanced algorithms are poised to accelerate genomic data processing, allowing researchers to extract valuable insights from complex datasets with unprecedented speed and accuracy. This shift is particularly impactful in personalized medicine and clinical diagnostics, where the demand for swift and precise genetic information is growing. As AI and ML continue to evolve, they are expected to drive innovation in DNA sequencing applications, ultimately transforming healthcare into a more data-driven landscape that caters to individualized patient needs.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape
• Case Studies
• Customer & Buying Criteria Analysis

Global DNA Sequencing Market Size by Product & Service & CAGR (2024-2031)

• Market Overview
• Consumables
• Instruments
• Services

Global DNA Sequencing Market Size by Technology & CAGR (2024-2031)

• Market Overview
• Sanger Sequencing
• Next-Generation Sequencing
  • Whole Genome Sequencing (WGS)
  • Whole Exome Sequencing (WES)
  • Targeted Sequencing & Resequencing
• Third Generation Sequencing
  • Single-Molecule Real-Time Sequencing (SMRT)
  • Nanopore Sequencing

Global DNA Sequencing Market Size by Workflow & CAGR (2024-2031)

• Market Overview
• Pre-sequencing
• Sequencing
• Data Analysis

Global DNA Sequencing Market Size by Application & CAGR (2024-2031)

• Market Overview
• Oncology
• Reproductive Health
• Clinical Investigation
• Agrigenomics & Forensics
• HLA Typing/Immune System Monitoring
• Metagenomics, Epidemiology & Drug Development
• Consumer Genomics
• Others

Global DNA Sequencing Market Size by End-use & CAGR (2024-2031)

• Market Overview
• Academic Research
• Clinical Research
• Hospitals & Clinics
• Pharmaceutical & Biotechnology Companies
• Other Users

Global DNA Sequencing Market Size & CAGR (2024-2031)

• North America, (Product & Service, Technology, Workflow, Application, End-use)
  • US
  • Canada
• Europe, (Product & Service, Technology, Workflow, Application, End-use)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific, (Product & Service, Technology, Workflow, Application, End-use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America, (Product & Service, Technology, Workflow, Application, End-use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa, (Product & Service, Technology, Workflow, Application, End-use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Illumina, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pacific Biosciences (PacBio)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oxford Nanopore Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qiagen
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Element Biosciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MGI (BGI Group)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genewiz
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Macrogen
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OncoDNA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hamilton Thorne
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DNASTAR
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins GATC Biotech
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wasatch BioLabs
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integrated DNA Technologies (IDT)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genomatic AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation